Description
Used in the treatment of:
- Metastatic colorectal cancer
- Lung, kidney, and ovarian cancers
Bevacizumab is a monoclonal antibody that inhibits VEGF, preventing new blood vessel growth required by tumors for survival and metastasis.
Support Email: info@biomedspecialitypharma.com
PRODUCT SPECIFICATION
Strength / Dose: 400 mg/16 mL per vial
Dosage Form: Concentrate for intravenous infusion
Packing Type: Single-use glass vial, packed in carton
Treatment:
Used in the treatment of:
Prescription Type: Prescription only (Rx)
Generic Name (Drug Name): Bevacizumab
Brand: Bryxta 400
Used in the treatment of:
PRODUCT SPECIFICATION
Strength / Dose: 50 mg per tablet
Dosage Form: Oral tablet
Packing Type: Tablets in blister or bottle, packed in carton
Treatment: Used in the treatment of various malignancies (e.g., lymphomas, leukaemias, solid tumours) and sometimes in non-oncology immunosuppressive settings (as per approved uses)
Prescription Type: Prescription only (Rx)
Generic Name (Drug Name): Cyclophosphamide
Brand: Cycloxan
PRODUCT SPECIFICATION
Strength / Dose: 500 mg per tablet
Dosage Form: Oral tablet
Packing Type: Tablets in blister or bottle, packed in carton
Treatment: Used in the treatment of metastatic castration‐resistant prostate cancer (mCRPC) in combination with other therapies (as per approved indication)
Prescription Type: Prescription only (Rx)
Generic Name (Drug Name): Abiraterone Acetate
Brand: Zybiraa-500
Our global distribution network and regulatory expertise enable us to deliver world-class pharmaceutical products that meet local market needs.
Address: DGS Sheetal Regalia, 209, Nensey Colony, Borivali East, Mumbai, Maharashtra 400066
Support mail: info@biomedspecialitypharma.com
Opening Hours: Monday – Saturday: 10.00am – 08.00pm